The complexities and caveats of lineage tracing in the mammary gland by Anne C. Rios et al.
LETTER Open Access
The complexities and caveats of lineage
tracing in the mammary gland
Anne C. Rios1,2†, Nai Yang Fu1,2†, Joseph Cursons3,4, Geoffrey J. Lindeman1,5,6 and Jane E. Visvader1,2*
Abstract
Lineage tracing is increasingly being utilised to probe different cell types that exist within the mammary gland.
Whilst this technique is powerful for tracking cells in vivo and dissecting the roles of different cellular subsets in
development, homeostasis and oncogenesis, there are important caveats associated with lineage tracing strategies.
Here we highlight key parameters of particular relevance for the mammary gland. These include tissue preparation
for whole-mount imaging, whereby the inclusion of enzymatic digestion can drastically alter tissue architecture and
cell morphology, and therefore should be avoided. Other factors include the scoring of clones in three dimensions
versus two dimensions, the timing of induction, and the marked variability in labelling efficiency that is evident not
only between different mouse models harbouring a similar gene promoter but also within a given strain and even
within a single mammary gland. Thus, it becomes crucial to visualise extensive areas of ductal tissue and to
consider the intricacies of the methodology for lineage tracing studies on normal mammary development and on
potential ‘cells of origin’ of cancer.
A recent report by Wuidart and colleagues [1] describes
several important limitations associated with lineage
tracing strategies pertinent to the mammary gland.
These include the nature of the transgenic or knock-in
(KI) model, the degree of chimerism, and the need for a
rigorous analysis of clones post-labelling. Additional
considerations relevant to lineage tracing in the mam-
mary gland are discussed below. Taken together with
those raised in [1], these parameters likely account for
disparities between lineage tracing data in the mammary
gland biology field. Nonetheless, substantial evidence
indicates the presence of both unipotent and bipotent
mammary stem cells (MaSCs) (reviewed in [2]). It seems
probable that bipotent cells help fuel the expansion of
unipotent stem/progenitor cells when required and thus
are biologically relevant.
Preparation of whole-mounted mammary glands
for three-dimensional (3D) confocal analysis
Protocols that utilise proteolytic digestion [1] may affect
tissue organisation and compromise mammary ductal
tree integrity. Comparison of tissues prepared with and
without enzymatic digestion revealed that even low con-
centrations of proteolytic enzymes can lead to a striking
depletion of cells in the outermost myoepithelial layer
(Fig. 1a–c), evident as gaps. Thus, destruction of the
basal lamina by enzymatic digestion appears to pro-
foundly change the morphology of myoepithelial cells
such that they lose their characteristic elongated shape
and become rounded (Fig. 1b and c). As a consequence,
their physical interactions with luminal cells can be lost,
with significant implications for clonality studies
(Fig. 1d). Tissues that lack elongated cells such as the
prostate [3] may not show sensitivity to the same diges-
tion conditions. Indeed, Wuidart et al. [1] could readily
track bipotent stem cells in the prostate under the same
preparation conditions.
Clonal analysis in 3D
It is advantageous to score clones in 3D to establish
whether cells are directly adjacent [4]. A luminal and
myoepithelial cell may be touching in 3D but this is not
always apparent within 2D data. Myoepithelial cells span
100 microns while luminal cells are smaller and a single
myoepithelial cell can contact multiple luminal cells.
Remarkably, a single 70 micron myoepithelial cell can
even contact 17 luminal cells (Fig. 1e–g). Visualisation
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of the four colours of the Confetti locus by native fluor-
escence in 3D allows scoring of around 100 clones in
1–2 days in a rather laborious procedure. In the clonal
analysis of K5rtTA/TetO-cre/R26R-Confetti mice at
1 week post-induction in the adult [4], the identifica-
tion of unicoloured clusters comprising both myoe-
pithelial and luminal cell types was clear, while abutting
luminal and myoepithelial cells of different colours
were very rare in tilescans that covered millimetres of
contiguous ducts, underscoring the importance of 3D
imaging to identify bipotent stem cells.
Using 3D confocal imaging, similar data were obtained
and enumerated for the K14creER model addressed in
Wuidart et al. [1]. In K14creER/R26R-YFP glands, we
observed 1–2% labelled luminal cells versus ~40% basal
cells at 2 days post-induction in the adult [4] (unpub-
lished data). No labelling of luminal cells occurred prior
to induction. Analysis of sparsely populated ducts in
K14creER/R26R-Confetti mice pulsed in adulthood for
8-weeks revealed 49% myoepithelial-only, 48% mixed,
and 3% luminal-rich mixed clones. To directly address
the probability of unicoloured vs multicoloured dou-
blets/clusters, we enumerated all cells and clusters (2–5
cells) in a ductal region of K14creER/R26R-Confetti
mammary glands that displayed very sparse labelling
(unpublished data). Scoring revealed 93.4% unicoloured
(including bilineage) vs 6.6% multicoloured clusters. The
majority of cells scored in 3D corresponded to single
myoepithelial cells, and the next most represented group
was myoepithelial doublets/triplets of the same colour.
In the case of multicoloured clusters, it should be noted
that there was one comprising a GFP+ (nuclear) luminal
cell and a different coloured myoepithelial cell, but that
a GFP+ myoepithelial cell was located in very close prox-
imity (one cell away). If the null hypothesis is that clus-
ters are equally likely to be the same or different
colours, then the two-sided p value is 8.7e–7 (using an
exact binomial test). Thus, the presence of unicoloured
bipotent clones is statistically significant. Importantly,
no luminal-only clones were detected in the K5rtTA,
K14creER, or huK5creER/YFP models [4]. Collectively,
these 3D data argue against chance (or ‘leaky’) induction
of neighbouring unipotent luminal progenitors in these
basal models.
Efficiency of cell labelling
The efficiency of labelling is crucial, as indicated by
Wuidart et al. [1], and different strategies have been
applied between groups. We aimed for a more substan-
tial degree of labelling to allow detection of stem cells
since they are estimated to comprise about 5% of the
heterogeneous basal population [5, 6], and Keratin (K)5
and K14 mark the entire basal population. The level of
labelling varied dramatically between models, between
individual mice of a given strain but also within a single
mammary gland. Even when the labelling frequency was
30%, not all areas of the tree exhibited the same degree
of labelling. A striking example of this variation is shown
in Fig. 1h and i, where two regions from the same mam-
mary gland of a K5-KI/R26R-tdTomato mouse show dif-
ferences in labelling. Although predominantly expressed
in the basal lineage as originally reported [7], clear evi-
dence for bipotent stem cells was obtained upon a
higher degree of labelling (using a low dose of tamoxi-
fen). In branches comprising fewer labelled cells, only
K5+ myoepithelial cells were evident, perhaps owing to
insufficient cre expression to activate recombination.
FACS analysis of K5-KI/R26R-tdTomato mice (>6) con-
firmed that 10–15% of Tomato+ cells corresponded to
luminal cells when the labelling efficiency of the basal
population was greater than 60%. Given the observed
variation in labelling between different ducts within the
same mammary gland, and likely differences amongst
stem cells in different regions, it is essential to visualise
millimetres of ductal tissue in 3D. In addition, tamoxifen
(See figure on previous page.)
Fig. 1 Influence of whole-mount preparation and efficiency of labelling on lineage tracing outcomes. a Whole-mount three-dimensional (3D)
confocal image of an intact ductal portion immunostained for Keratin 5 obtained using a protocol that does not include any enzymatic digestion
(described in Rios et al. [4]). Scale bar= 50 μm. b Whole-mount 3D confocal image of a ductal portion (8-week-old FVB/N mouse) immunostained for
Keratin 5 (green) and E-cadherin (red), using the protocol described by Wuidart et al. for enzymatic digestion of mammary glands [1]. The mammary
portions were subsequently fixed in 4% paraformaldehyde (PFA) for 2 h at 4 °C, and processed as described in Rios et al. [4] for immunostaining and
confocal imaging. c Image of an enlargement from (b) showing the myoepithelial layer immunostained for Keratin 5. Note the paucity of myoepithelial
cells and their altered shape, which is no longer elongated. Scale bars= 100 μm (b) and 30 μm (c). d Schematic panels showing normal contacts between
one myoepithelial cell (myo, in green) and multiple luminal cells (lum, in red) in intact breast tissue (left), and loss of cell-cell contacts
between the myoepithelial (in green) and luminal cells (in red) after enzymatic digestion (right). e Whole-mount 3D confocal image
(from Fig. 1d, Rios et al. [4]) of a duct in a K5rtTA-IRES-GFP mammary gland immunostained for E-cadherin (in blue). f enlargement from (e), showing
a mask (in red) applied to one myoepithelial cell (GFP channel using Imaris software) and the luminal layer labelled with E-cadherin (in blue). g Image
showing the mask of the myoepithelial cell and the masks of all luminal cells in direct contact with the myoepithelial cell. Note: the mask was applied
to a representative 70 μm myoepithelial cell. Scale bars= 50 μm (whole-mount e) and 10 μm (enlargements f, g). h, i Whole-mount 3D confocal
images of ducts in a K5-KI/R26R-tdTomato mammary gland, showing either a high (h) or low (i) degree of labelling in the same gland, at 4 weeks
post-induction with tamoxifen in adulthood and then immunostained for E-cadherin (blue). Enlargements show optical sections depicting luminal
cell-containing clones (upper panel) or elongated myoepithelial cells (lower panel). Scale bars = 200 μm (whole-mounts) and 50 μm (enlargements)
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continues to be a concern as the field uses varying doses
of tamoxifen, which can affect labelling efficiency and
read-out, given its pronounced effect on the basal and
luminal lineages [4, 8].
A labelling efficiency of around 100% has been recently
reported for the K14rtTA model [1], with labelled progeny
restricted to unipotent myoepithelial stem cells. We agree
that this model is largely unipotent. However, 3D imaging
of millimetres of ductal tissue from K14-rtTA/TetO-cre/
R26R-tdTomato mice (achieving 89% saturation labelling
of basal cells) revealed the presence of rare bi-lineage
clones comprising directly abutting luminal and myoe-
pithelial cells, thus arguing against nonspecific labelling
(data not shown).
Timing of induction for clonal analyses
Mammary gland development is relatively complex and
occurs in multiple phases. Therefore, an additional consid-
eration for mammary gland lineage tracing strategies is
the timing of labelling induction for clonal analyses. MaSC
populations will inevitably differ in their behaviour and
location during development (embryonic and pubertal)
versus the adult stage (ductal maintenance and remodel-
ling during reproduction) due to different physiological
requirements. For clonal analysis, induction should be
performed during the adult stage and not in puberty. This
is due to the nature of elongation that occurs from the
highly proliferative, multilayered terminal endbuds during
puberty and the movement of cells to form the subtending
duct that preclude the spatial identification of clones dur-
ing this morphogenic stage.
Implications for data quantification
Wuidart et al. [1] recently established a statistical model
that describes the relative frequency of adjacent unicol-
our pairs (UPs) within tissue data. However, we believe
that proteolytic digestion applied for tissue processing
[1] has the potential to introduce artefacts into the
quantitative data used to inform their statistical model,
since it affects the morphology of myoepithelial cells and
thus the number of neighbouring cells. The myoepithe-
lial cell shown (Fig. 1e–g) contacts 17 luminal ductal
cells, greatly exceeding the maximum value of 7 reported
by Wuidart et al. Although an increase in the number of
neighbouring cells will increase the number of adjacent
UPs expected by chance, it would also greatly increase
the observed number of UPs, highlighting the complex
effects of tissue preparation upon data quantification. In
addition, the model does not account for the low fre-
quency of labelling of MaSCs compared to other cell types
in the mouse models examined. MaSCs are also unlikely
to be homogeneously distributed throughout the ductal
tree (unpublished data). In the future, mathematical mod-
elling will provide a powerful means to interrogate cellular
dynamics and the spatial localisation, but care must be
taken when interpreting the image data and quantifying
model parameters. More extensive image data obtained
using refined genetically engineered mouse strains that
allow different populations to be marked will help guide
the development of such models.
Concluding remarks
It is clear that the precise cre strain, even using similar
transgenic promoter segments, can drastically influence
the outcome of lineage tracing studies. Moreover, a
negative result in lineage tracing does not prove that a
cell type does not exist. Rather, it can reflect the cre
driver or methodology employed. To track MaSCs in
vivo, the field requires highly specific gene promoters
for these cells. The Lgr5 gene has been previously
shown to be basally restricted in the adult [9–11] and
to mark a subset of basal cells that includes bipotent
MaSCs [4]. Wuidart et al. [1] now report that up to
40% of labelled cells correspond to luminal cells yet
conclude that Lgr5 does not mark any bipotent cells.
Procr is also more restricted than the basal keratin
genes and has been shown to mark bipotent stem
cells by lineage tracing [12]. Interestingly, it has
proven difficult to track hematopoietic stem cells in vivo
using lineage tracing methods, but it is widely accepted
that these cells are critical for blood development and
cancer [13, 14]. We believe that the overarching question
for the mammary gland field is not whether bipotent stem
cells exist, but instead what is the relative contribution of
bipotent versus unipotent stem cells to the different stages
of post-natal mammopoiesis?
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